Study gene activity in people with heart failure or aortic stenosis
Part of Heart & circulation clinical trials.
This trial looks at patterns in your blood or heart-related “gene activity” (transcriptome) after heart procedures. It may help doctors understand why some people with heart failure or aortic valve narrowing (stenosis) do better than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 40–75
- You have heart failure that is not “end-stage,” or you have end-stage heart failure
- For heart failure, your heart pumping strength (ejection fraction) is in a specific low range
- You must have had heart procedures for either heart failure (SVR or LVAD) or aortic stenosis (valve replacement)
- If you have aortic stenosis, your test results must show high pressure across the valve
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the biological causes of heart failure, including genes and other molecules, to better understand the disease. It may help researchers find new ways to treat heart failure in the future.
This study looks for biological markers in the blood that might help predict heart-related events in people with a narrowed aortic heart valve. It aims to improve care for those with this condition, whether or not they have a procedure called TAVI to replace the valve.
This study looks at how heart mechanics, blood markers, and frailty relate to symptoms and heart measurements in people with aortic stenosis (a stiff, narrowed heart valve). It may help doctors better understand who is at higher risk and how disease changes over time.
This study looks at how genes affect heart failure treatment response. It uses blood samples to find new markers that may help predict who will benefit most from therapy.
This study tests whether remote monitoring (checking in from home) can help people with a common heart valve condition called aortic stenosis. It aims to see if this approach can keep you out of the hospital and improve your quality of life.
This study looks at blood and/or body signals (called biomarkers) to understand why aortic valve narrowing may worsen and what outcomes people have. You may be able to help researchers by undergoing regular heart care plus additional testing like MRI or CT if you qualify.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.